“Quantitative Analysis Of CD133 & OCT 4 As Prognostic Markers In Oral Squamous Cell Carcinoma”, Journal of Pharmaceutical Negative Results, pp. 2801–2811, Feb. 2023, doi: 10.47750/pnr.2023.14.03.354.